GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD.

J Crohns Colitis · 2019 · PMC6434738 · PMID 30312386

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantp = 0.06so close (0.05 < p ≤ 0.1)

Disease location was associated with GlycA levels, with a Wilcoxon test showing a borderline significant [ p = 0.06] difference between GlycA levels of L1 and L3 CD patients, and UC patients with E1 disease showing significantly lower GlycA levels than those of E2/E3-afflicted patients [wilcoxon p = 0.04].

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.